Uncategorized Archives - Page 70 of 251

WednesdayAug 04, 2021 11:46 am

American Cannabis Partners Success Lies in the Details and its Values

ACP operates in two states and has strategic plans in place to expand into two more by 2024 Partnerships have allowed the recreation of the exact soil conditions, growing supplements, water makeup, and environment of Orange Hill in Jamacia Junior Gordon, the Cultivation Manager of ACP, is an award-winning and highly sought after grower whose focus is primarily on plant health The privately-owned American Cannabis Partners ("ACP"), a large scale organic cannabis cultivation company, is headquartered in Northern California but also has a foothold in Michigan. Since its beginning in 2018, ACP has acquired 12 cannabis licenses, 20,000 sq. ft of…

WednesdayAug 04, 2021 11:12 am

RYAH Group Inc. (CSE: RYAH) Supporting U.S. Changes in Cannabis Research

New cultivators have approved for federally funded studies in the U.S., and 575 DEA-licensed researchers are standing by, ready for the change RYAH's ecosystem of products allows data to be collected from seed to consumption, providing a holistic view of the plant necessary for optimal research RYAH continues to expand its global clinical and distribution network for plant-based medicine and digital patient care The U.S. is putting an end to its 50-year long prohibition on Cannabis Research (https://cnw.fm/UOoHf). New cultivators have now been approved for federally funded studies. With over 575 DEA-licensed researchers across the U.S., the future of cannabis…

TuesdayAug 03, 2021 9:30 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Is ‘One to Watch’

InMed has a world class leadership team with a successful track record of drug development and commercialization The company recently announced closing of a $12 million private placement InMed has a solid and expanding intellectual property portfolio with multiple patents filed The company recently signed an LOI to acquire rare cannabinoids manufacturer BayMedica InMed retains all commercial rights to its IntegraSyn manufacturing system InMed has filed clinical trial applications in several countries as part of a Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa The consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to…

TuesdayAug 03, 2021 9:00 am

Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Names New Executive, Retains PR Firm

CHALF appoints retail veteran Ginger Mollo as chief integration officer, Fifth & Root GM Mollo will oversee the positioning, expansion of the Fifth & Root Brand within the health and wellness beauty market as well as integration into Chalice brands Chalice has engaged MP-IMC to heighten profile of Fifth & Root in Chalice Brands product portfolio Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, has appointed retail veteran Ginger Mollo as chief integration officer for the company. In addition, Mollo will also serve as general manager of Fifth &…

MondayAug 02, 2021 10:00 am

American Cannabis Partners Poised for Expansion, Seeks Growth Opportunities as Reliable Business Partner

ACP's strategy is based on leveraging opportunities in real estate and licensing in states that have recently passed legalization legislation Focused on complementary business segments — real estate, acquisition and development of proprietary assets, and ongoing cultivation operations, ACP appears poised for expansion Company seeks partnerships with companies with aligned personal, ethical, and business sensibilities to differentiate itself in assets, services, research, and philanthropy American Cannabis Partners (“ACP”) is a licensed, large-scale, and 100% organic cultivation company supplying multiple forms of raw product at consistent wholesale prices for manufacturing, distribution, and retail licenses. The company is considering additional growth via…

MondayAug 02, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Achieving Its Operational and Business Plan Objectives

Lexaria just completed dosing for its second human clinical study, HYPER-H21-2 The study sought to understand the human response to Lexaria’s DehydraTECH 2.0-enabled CBD The company also announced that its DehydraTECH-enabled consumer products are available for purchase in over 7,000 stores across the United States Lexaria also expanded its intellectual property portfolio with the allowance of its second patent in Japan It also received US$3,817,643 from warrant exercises, proceeds from which will be used to advance the company’s research and development program and for its general corporate purposes Lexaria Bioscience (NASDAQ: LEXX) has been making incredible strides in 2021 as…

FridayJul 30, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Announces Armageddon Event, First-Ever Production of Its Kind

Epic stage production features a unique end-of-the-world theme Company is curating a theme to create a ground-breaking production With more than 30,000 national followers, EpicRaves is on its way to achieving goal of becoming nationally recognized concert production company Golden Triangle Ventures (OTC: GTVH) is making company history with the announcement of its debut event series: Armageddon (https://cnw.fm/bblOQ). This epic stage production features a unique end-of-the-world theme and is the company’s first-ever offering of this kind. “We will deploy the largest Hennessy Sound Design system Las Vegas has ever seen in history for this amazing event, and we are going…

FridayJul 30, 2021 9:00 am

Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Reports Record Q2 2021 Revenues

Company executed record quarter by focusing on profitable operations, accretive acquisition of Homegrown Oregon Chalice posts record quarterly revenue, gross profit numbers Homegrown chain of five stores joined the Chalice brand earlier this year Chalice Brands (CSE: CHAL) (OTCQB: CHALF) has released its 2021 second-quarter unaudited financial, noting highest-ever quarterly revenues, along with other promising numbers (https://cnw.fm/N4NXU). The company is a premier consumer-driven company specializing in the retail, production, processing, wholesale and distribution of cannabis. “We are immensely proud to execute another record quarter by focusing on profitable operations and the accretive acquisition of Homegrown Oregon,” stated Chalice CEO and…

ThursdayJul 29, 2021 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hails Successful Testing for Effective Transformation of Antivirals for Greater Bioavailability

Lexaria Bioscience is a drug delivery technology developer advancing its IP for transforming existing consumer products and medications that may improve their availability and bioavailability The analysis of Lexaria’s DehydraTECH(TM) shows it did not create unwanted new molecular entities during the transformation process, did not inhibit the drugs’ expected antiviral functions and did increase absorption The DehydraTECH testing has been in conjunction with drugs used to treat SARS-CoV-2/COVID-19, HIV/AIDS and hepatitis, although the company envisions its technology becoming responsive to a much wider array of viral illnesses The company envisions building on its recent successes with larger studies of the…

ThursdayJul 29, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Globally Unlocking Data in the Complete Therapeutic Plant Lifecycle

Providing a holistic approach to therapeutic plant treatment by unlocking data from seed to consumption RYAH Group is providing needed dosing devices globally to drive innovation and deliver cutting edge plant-based medical solutions globally With over 200k registered users, RYAH Group is one of the largest plant-based medicine databases in the world and regularly releases and shares valuable insights collected RYAH Group (CSE: RYAH), formerly RYAH Medtech, is leading the way forward by providing a holistic approach to therapeutic plant treatment by unlocking the data in the complete plant lifecycle (seed to consumption). Known for its high-quality information and digital…